Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment.
about
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African childrenPopulation Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients.Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial
P2860
Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efavirenz dosing: influence of ...... urrent tuberculosis treatment.
@en
type
label
Efavirenz dosing: influence of ...... urrent tuberculosis treatment.
@en
prefLabel
Efavirenz dosing: influence of ...... urrent tuberculosis treatment.
@en
P50
P356
P1433
P1476
Efavirenz dosing: influence of ...... urrent tuberculosis treatment.
@en
P2093
Julia H Botha
P304
P356
10.3851/IMP2877
P577
2015-10-15T00:00:00Z